Navigation Links
TPI Reports Second Quarter Fiscal Year 2013 Financial Results
Date:2/14/2013

ndication for GMOL: cardiovascular disorders, coronary heart disease and cerebral ischemic attack including strokes, off-label use of GMOL have been indicated in hepatic diseases and ophthalmological diseases. The validity of these observations is currently being investigated.

Jiangchuan Macrolide Project (JCM)

TPI has completed the 240-ton JCM facility for the R&D, manufacturing and sale of API and chemical intermediates of macrolide antibiotics. In January 2012, JCM was approved for its GMP certification designated as "CHUAN M0799," which is valid for the period of December 31, 2011 until December 31, 2015. After an initial three month period of efficiency improvement and calibration for large scale production, JCM has started producing macrolide API for TPI's production of Azithromycin Dispersible Tablets (SFDA No: H20074145) since July 2012. Currently the monthly production capacity of JCM is 10 tons of Azithromycin macrolide API.

Tianyin Medicine Trading Distribution Business (TMT)

TMT is established to distribute products manufactured by both TPI and other pharmaceutical companies to fuel our expanding sales network as well as to provide synergy to our existing organic product portfolio. TMT has been distributing mainly TPI's own products since its inception in 2009. Since 2010, TPI has signed and later extended distribution contracts with Jiangsu Lianshui Pharmaceutical ("Lianshui") to distribute Lianshui-branded generic injection products including cough suppressant, antibiotics, anti-inflammatory medicines and other healthcare indications. On average, TMT distribution revenue contributed approximately $3-5 million sales per quarter to our total revenue.

Pre-extraction and formulation plant development at Qionglai Facility (QLF)

In preparation for the new Good Manufacturing Practice (GMP) standards stipulated by the PRC government in early 2011, TPI initiated the process of optimizing th
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Regeneron Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
2. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
3. Hospira Reports Fourth-Quarter and Full-Year 2012 Results
4. Cynosure Reports Record Revenues for Fourth-Quarter and Full-Year 2012
5. Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results
6. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
7. Allied Healthcare Products Reports Second Quarter Loss
8. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
9. Pharmaceutical Market & Biotechnology Industry 2013 Outlook in New Research Reports at ReportsnReports.com
10. Misonix Reports Financial Results for First Half of Fiscal 2013
11. CareFusion Reports First Half Fiscal 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige ... erworben zu haben. Mit dieser Übernahme dringt ... mit einem Umsatz von 765 Mrd. RUB ... Pharmamärkten der Welt gehörte (IMS Health). Seit ...
(Date:7/2/2015)... BOMBAY , July 3, 2015 ... la adquisición del 100% de participación en ZAO ... La adquisición marca la incursión de Lupin en ... millones de RUB en ventas, colocándolo como uno ... en 2014 (IMS Health). Durante más de una ...
(Date:7/2/2015)... VANCOUVER , July 2, 2015 /PRNewswire/ - ... today that its common shares have been approved for listing ... symbol "EPIX". ESSA will begin trading on NASDAQ ... on the TSX Venture Exchange under the symbol "EPI". ... shares on the NASDAQ, each of the Company,s outstanding special ...
Breaking Medicine Technology:Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4
... 2011 Elanco, the animal health division of Eli ... announced that Lilly has made an irrevocable, unconditional offer ... NV, a Johnson & Johnson Company. The two companies ... intentions. Headquartered in Beerse, Belgium, Janssen,s animal health business ...
... BEVERLY, Mass., March 14, 2011 Cellceutix Corporation ... the Company,s flagship compound for the potential treatment ... cancers), has begun production for clinical trials. This ... which formulates developmental medications for clinical trials. ...
Cached Medicine Technology:Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 2Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health 3Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun 2Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun 3
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in 2015, ... of an annual member survey , detailing the most common plastic surgery and ... broke that raw data down into charts detailing demographic trends and regional preferences. ...
(Date:7/4/2015)... , ... July 04, 2015 , ... ... solar industry’s leading recognition of technical sales expertise from the North American Board ... Sales ProfessionalTM. NABCEP is the most highly respected and well established national certification ...
(Date:7/3/2015)... ... , ... On June 30th SEO authority and veteran Internet ... "Page One Engine" . The program, which has been hailed as the ... well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an in-depth review ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon ... for the 2016 Dallas Rhinoplasty Symposium . To be held from March 4th ... will be held at the Westin Galleria Dallas. , Designed to take participants from ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Lecture took place on June 25, 2015 at 1:00pm. The Association welcomed speaker ... issues pertaining to injured bicyclists and practical points of investigating these types of ...
Breaking Medicine News(10 mins):Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... Reporter , MONDAY, April 16 (HealthDay News) -- Accidental ... since 2000 but still remain the number-one killer of ... the U.S. Centers for Disease Control and Prevention on ... injuries in the U.S. in 2009," said CDC principal ...
... (HealthDay News) -- Off-label prescribing of medications is common, ... and doctor characteristics, a Canadian study finds. In ... have not been approved by regulators. For example, some ... chronic pain. The practice, which is legal ...
... have developed an inexpensive, battery-powered neonatal monitor for infants ... Five bioengineering students created the Babalung Apnea Monitor ... of all graduating engineering students at Rice. The device ... adjustable strap with a stretch sensor. ...
... emergency room visits for young children each year than do ... 1 of every 4 grandparents says that they store prescription ... The University of Michigan Mott Children,s Hospital National Poll ... aged 1 to 5 years about the presence of medicines ...
... study describes a therapeutic approach to halting cancer progression ... to specific signaling molecules. The research, published by Cell ... Cancer Cell , identifies non-classical oncogenes critical for tumor ... strategy that selectively targets these molecules. Many cancers ...
... (HealthDay News) -- A large international group of researchers has ... Variations in these regions could offer protection from, ... a new study published in the April 15 online edition ... that their findings could lead to the development of new ...
Cached Medicine News:Health News:Death From Accidental Injuries Among Kids Drops 30%: CDC 2Health News:Death From Accidental Injuries Among Kids Drops 30%: CDC 3Health News:'Off-Label' Drug Use Appears Common 2Health News:Babalung gets babies breathing again 2Health News:Babalung gets babies breathing again 3Health News:Nearly 1 in 4 grandparents store prescription medicines where children can easily find them 2Health News:Therapy exploits 'addiction' of leukemia cells 2Health News:Certain Genetic Regions May Be Tied to Osteoporosis 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: